MAPLE GROVE , Minn. – Upsher-Smith announced Tuesday the recent launch of vigadrone (vigabatrin) tablets, USP 500 mg, a fully substitutable, AB-rated generic version of Sabril (vigabatrin) Tablets, 500 mg. The company also offers vigadrone (vigabatrin) for Oral Solution, USP 500 mg.
VIGADRONE® (vigabatrin) Tablets, USP 500 mg.
VIGADRONE® (vigabatrin) for Oral Solution, USP 500 mg.
Upsher-Smith Laboratories, LLC.
“Upsher-Smith is always looking for innovative and impactful ways to make prescribing our products easier for physicians and more accessible to patients,” said Rich Fisher, president and COO, Upsher-Smith. “We understand the challenges associated with prescribing and accessing specialty drugs, particularly vigabatrin, and our team is committed to providing service and support that helps give peace of mind to our providers and patients.”
To learn more about the vigadrone family of products and Upsher-Smith’s support program, visit vigadrone.com.
